The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...

Laekna (2105.HK) announced today that the results of: i) the phase I SAD study of LAE102 (an ActRIIA-selective antibody) for ...

Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical ...

Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...

Phase 3 Top Line Results Expected Q2 2026 SALT LAKE CITY, June 26, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its ...

Phase 3 study met primary and most key secondary clinical endpoints This marks the third developmental and epileptic encephalopathies (DEE) population for fenfluramine ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

A mentorship program for neonatal nurse practitioners in Tennessee receives positive feedback from mentor and mentee ...

Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after ...

A research team was looking to make a new anti-inflammatory medication when they found some incredible side effects ...